Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic Gastropathy
Clinical trial NCT00142974 · TERMINATED
Trial details
- NCT number
- NCT00142974
- Sponsor
- Novartis
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2005-04-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.